20th December 2022 OncoLize has joined forces with a small but highly specialized consortium around the department of Engineered Therapeutics led by prof. dr. Jai Prakash from the University of Twente in the Netherlands. The Read more…
14th April 2023. Leiden-based Dutch start-up OncoLize has closed a US$ 1.7 million first round to extend their preclinical success with a localized drug delivery system to treat Pancreatic- and Lung cancer. The round was Read more…
15th December 2022 – The USPTO has granted the patent application valid by RCSI covering the OncoLize technology. This broad base patent describes the composition-of-matter and various formulations and applications essential to the oncology business Read more…
Mike de Leeuw was invited to write an expert column in a special feature of ‘Het Financieel Dagblad’ covering a.o. oncology development in the Netherlands. You can read the column here.